CTRI/2020/05/025215已完成1 期
A prospective, single centre, randomized open labelled comparative clinical study to evaluate the effectiveness of Siddha medicine, Kabasura kudineer and vitamin c-zinc supplementation in the management of asymptomatic COVID 19 patients.
Dean0 个研究点目标入组 60 人开始时间: 待定最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Laboratory confirmed COVID-19 without symptoms
- •2.Consenting to participate in the study and sign the informed consent
排除标准
- •1.Patient with co morbid conditions like DM, HT, BA
- •2.Patients with severe primary respiratory disease or other pathogenic microbial pneumonia that needs to be identified with COVID-19
- •3.Pregnant and mothers, those who have a pregnancy plan.
- •4.Patients with other systemic malignant diseases such as malignant tumors, mental illnesses, etc., which the researchers consider unsuitable for participation in the study
- •5.People who have been allergic to Siddha medicine or intolerant to taking medicine
- •6.Patients participating in other COVID-19 clinical trials
研究者
相似试验
尚未招募
不适用
Aggressive versus conservative endoscopic therapy for gastric varicesCTRI/2022/02/040188Surat Institute of Digestive Sciences
已完成
不适用
A single-center, prospective, randomized, open-label, clinical trial of ceramide 2-containing hydrocolloid dressings versus polyurethane film dressings for pressure ulcer prevention in high-risk surgical patientsPressure ulcerJPRN-UMIN000019420Pressure Ulcer Committee of Tokyo Medical University Ibaraki Medical Canter128
尚未招募
4 期
A prospective, single-center, randomized, open-label, parallel-controlled clinical study on the efficacy and safety of Shenfu Injection in the treatment of septic shock (Syndrome of Yang-Qi collapse)Septic shockITMCTR2200006718Dongfang Hospital Beijing University of Chinese medicine
已完成
不适用
To evaluate the safety and efficacy of herbal / nutraceutical tablet plus standard of care when compared with only standard of care in patients with benign prostatic hyperplasia.CTRI/2022/05/042513Arogyaseva Medical Academy of India AMAI151
尚未招募
不适用
Safety and Efficacy of Artemisinin 500 mg capsule in Treatment of Adult Subjects with COVID-19Corona Virus COVID-19PACTR202012892855610Oncotelic Incorporated120